Measurement of liver and spleen stiffness as complementary methods for assessment of liver fibrosis in autoimmune hepatitis.
autoimmune hepatitis
liver fibrosis
liver stiffness
shear wave elastography
spleen stifness
transient elastography
Journal
Liver international : official journal of the International Association for the Study of the Liver
ISSN: 1478-3231
Titre abrégé: Liver Int
Pays: United States
ID NLM: 101160857
Informations de publication
Date de publication:
02 2021
02 2021
Historique:
received:
31
03
2020
revised:
09
10
2020
accepted:
31
10
2020
pubmed:
8
11
2020
medline:
22
6
2021
entrez:
7
11
2020
Statut:
ppublish
Résumé
Liver stiffness measurements (LSM), commonly performed by transient elastography (TE) or two-dimensional shear wave elastography (2D-SWE), are used to quantify liver fibrosis. Active hepatitis, a hallmark of autoimmune hepatitis (AIH), could bias LSM. This bias might be overcome by measurement spleen 2D-SWE. Here, we compare liver and spleen 2D-SWE to TE and liver biopsy (LB) in prospectively recruited patients with AIH. We analysed liver and spleen 2D-SWE in relation to liver TE in 90 patients treated ≥ 6 months for AIH. Liver and spleen 2D-SWE were also compared to LB in 63 individuals with AIH. Finally, we evaluated these tools in 220 patients with AIH and during 18 months follow-up. Liver 2D-SWE correlated with surrogate markers of active hepatitis (ALT and IgG, both P < .001) but there was no link between spleen 2D-SWE and ALT. Liver 2D-SWE, but not spleen 2D-SWE, was associated with histopathological inflammatory score (P < .01). When compared to LB, the optimal cut-offs for detecting cirrhosis by liver and spleen 2D-SWE were 16.1 kPa (AUROC 0.93) and 29.8 kPa (AUROC 0.95), respectively. In patients with active hepatitis the combined diagnostic approach including liver and spleen 2D-SWE had significantly better AUROC for detecting cirrhosis than liver 2D-SWE alone. Liver and spleen 2D-SWE are reliable complementary methods for the diagnosis of advanced fibrosis in AIH. Spleen 2D-SWE seems to be less biased by inflammation and could facilitate fibrosis assessment in therapy-naïve patients or in the presence of active hepatitis.
Sections du résumé
BACKGROUND AND AIMS
Liver stiffness measurements (LSM), commonly performed by transient elastography (TE) or two-dimensional shear wave elastography (2D-SWE), are used to quantify liver fibrosis. Active hepatitis, a hallmark of autoimmune hepatitis (AIH), could bias LSM. This bias might be overcome by measurement spleen 2D-SWE. Here, we compare liver and spleen 2D-SWE to TE and liver biopsy (LB) in prospectively recruited patients with AIH.
METHODS
We analysed liver and spleen 2D-SWE in relation to liver TE in 90 patients treated ≥ 6 months for AIH. Liver and spleen 2D-SWE were also compared to LB in 63 individuals with AIH. Finally, we evaluated these tools in 220 patients with AIH and during 18 months follow-up.
RESULTS
Liver 2D-SWE correlated with surrogate markers of active hepatitis (ALT and IgG, both P < .001) but there was no link between spleen 2D-SWE and ALT. Liver 2D-SWE, but not spleen 2D-SWE, was associated with histopathological inflammatory score (P < .01). When compared to LB, the optimal cut-offs for detecting cirrhosis by liver and spleen 2D-SWE were 16.1 kPa (AUROC 0.93) and 29.8 kPa (AUROC 0.95), respectively. In patients with active hepatitis the combined diagnostic approach including liver and spleen 2D-SWE had significantly better AUROC for detecting cirrhosis than liver 2D-SWE alone.
CONCLUSIONS
Liver and spleen 2D-SWE are reliable complementary methods for the diagnosis of advanced fibrosis in AIH. Spleen 2D-SWE seems to be less biased by inflammation and could facilitate fibrosis assessment in therapy-naïve patients or in the presence of active hepatitis.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
348-356Informations de copyright
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Références
Liberal R, de Boer YS, Andrade RJ, et al. Expert clinical management of autoimmune hepatitis in the real world. Aliment Pharmacol Ther. 2017;45(5):723-732. https://doi.org/10.1111/apt.13907
Lohse AW, Chazouillères O, Dalekos G, et al. EASL clinical practice guidelines: autoimmune hepatitis. J Hepatol. 2015;63(4):971-1004. https://doi.org/10.1016/j.jhep.2015.06.030
Tapper EB, Lok AS-F. Use of liver imaging and biopsy in clinical practice. New Engl J Med. 2017;377(8):756-768.
Wu S, Yang Z, Zhou J, et al. Systematic review: diagnostic accuracy of non-invasive tests for staging liver fibrosis in autoimmune hepatitis. Hepatol Int. 2019;13(1):91-101. https://doi.org/10.1007/s12072-018-9907-5
Castera L. Diagnosis of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: non-invasive tests are enough. Liver Int. 2018;38:67-70. https://doi.org/10.1111/liv.13658
Herrmann E, de Lédinghen V, Cassinotto C, et al. Assessment of biopsy-proven liver fibrosis by two-dimensional shear wave elastography: an individual patient data-based meta-analysis. Hepatology. 2018;67(1):260-272. https://doi.org/10.1002/hep.29179
Hartl J, Denzer U, Ehlken H, et al. Transient elastography in autoimmune hepatitis: timing determines the impact of inflammation and fibrosis. J Hepatol. 2016;65(4):769-775. https://doi.org/10.1016/j.jhep.2016.05.023
Dietrich C, Bamber J, Berzigotti A, et al. EFSUMB guidelines and recommendations on the clinical use of liver ultrasound elastography, update 2017 (Long Version). Ultraschall der Medizin. 2017;38(4):e16-e47. https://doi.org/10.1055/s-0043-103952
Alvarez F, Berg PA, Bianchi FB, et al. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31(5):929-938. https://doi.org/10.1016/S0168-8278(99)80297-9
Sterling RK, Lissen E, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology. 2006;43(6):1317-1325. https://doi.org/10.1002/hep.21178
Sporea I, Grădinaru-Taşcău O, Bota S, et al. How many measurements are needed for liver stiffness assessment by 2D-Shear Wave Elastography (2D-SWE) and which value should be used: the mean or median? Med Ultrason. 2013;15(4):268-272.
Procopet B, Berzigotti A, Abraldes JG, et al. Real-time shear-wave elastography: applicability, reliability and accuracy for clinically significant portal hypertension. J Hepatol. 2015;62(5):1068-1075. https://doi.org/10.1016/j.jhep.2014.12.007
Thiele M, Madsen B, Procopet B, et al. Reliability criteria for liver stiffness measurements with real-time 2D shear wave elastography in different clinical scenarios of chronic liver disease. Ultraschall der Medizin - Eur J Ultrasound. 2017;38(06):648-654. https://doi.org/10.1055/s-0042-108431
Boursier J, Zarski J-P, de Ledinghen V, et al. Determination of reliability criteria for liver stiffness evaluation by transient elastography. Hepatology. 2013;57(3):1182-1191. https://doi.org/10.1002/hep.25993
Goodman ZD. Grading and staging systems for inflammation and fibrosis in chronic liver diseases. J Hepatol. 2007;47(4):598-607. https://doi.org/10.1016/j.jhep.2007.07.006
Hartl J, Ehlken H, Sebode M, et al. Usefulness of biochemical remission and transient elastography in monitoring disease course in autoimmune hepatitis. J Hepatol. 2018;68(4):754-763. https://doi.org/10.1016/j.jhep.2017.11.020
Zeng J, Huang ZP, Zheng J, Wu T, Zheng RQ. Non-invasive assessment of liver fibrosis using twodimensional shear wave elastography in patients with autoimmune liver diseases. World J Gastroenterol. 2017;23(26):4839-4846. https://doi.org/10.3748/wjg.v23.i26.4839
Sun LL, Dong G, Wang B, Zheng Q, Wang S, Zhang RF. Real-time shear wave elastrography and apri index for evaluating autoimmune hepatitis fibrosis. J Biol Regul Homeost Agents. 2016;30(4):1019-1021.
Cassinotto C, Lapuyade B, Mouries A, et al. Non-invasive assessment of liver fibrosis with impulse elastography: comparison of Supersonic Shear Imaging with ARFI and FibroScan®. J Hepatol. 2014;61(3):550-557. https://doi.org/10.1016/j.jhep.2014.04.044
Pape S, Gevers TJG, Belias M, et al. Predniso(lo)ne dosage and chance of remission in patients with autoimmune hepatitis. Clin Gastroenterol Hepatol. 2019;17(10):2068-2075.e2. https://doi.org/10.1016/j.cgh.2018.12.035
EASL-ALEH Clinical Practice Guidelines: non-invasive tests for evaluation of liver disease severity and prognosis. European Association for Study of Liver, Asociacion Latinoamericana para el Estudio del Higado. 2015;63(1):237-264. https://doi.org/10.1016/j.jhep.2015.04.006
Chen S-H, Li Y-F, Lai H-C, et al. Noninvasive assessment of liver fibrosis via spleen stiffness measurement using acoustic radiation force impulse sonoelastography in patients with chronic hepatitis B or C. J Viral Hepat. 2012;19(9):654-663. https://doi.org/10.1111/j.1365-2893.2012.01588.x
Arena U, Vizzutti F, Corti G, et al. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology. 2008;47(2):380-384. https://doi.org/10.1002/hep.22007
Sato S, Tsubaki T, Kako M, Kanai K. Measurement of portal and splenic venous flow volume (PV and SV), congestion index (CI) and SV/PV% in various liver diseases using by Doppler echo-sonography. Nihon Shokakibyo Gakkai Zasshi. 1996;93(5):331-337.
Feizi T. Immunoglobulins in chronic liver disease. Gut. 1968;9:193-198. https://doi.org/10.1136/gut.9.2.193
Ehlken H, Wroblewski R, Corpechot C, et al. Validation of transient elastography and comparison with spleen length measurement for staging of fibrosis and clinical prognosis in primary sclerosing cholangitis. PLoS One. 2016;11(10):e0164224. https://doi.org/10.1371/journal.pone.0164224
Krawczyk M, Ligocka J, Ligocki M, et al. Does transient elastography correlate with liver fibrosis in patients with PSC? Laennec score-based analysis of explanted livers. Scand J Gastroenterol. 2017;52(12):1407-1412. https://doi.org/10.1080/00365521.2017.1370009
Jansen C, Möller P, Meyer C, et al. Increase in liver stiffness after transjugular intrahepatic portosystemic shunt is associated with inflammation and predicts mortality. Hepatology. 2018;67(4):1472-1484. https://doi.org/10.1002/hep.29612
Jansen C, Bogs C, Verlinden W, et al. Algorithm to rule out clinically significant portal hypertension combining Shear-wave elastography of liver and spleen: a prospective multicentre study. Gut. 2016;65(6):1057-1058. https://doi.org/10.1136/gutjnl-2016-311536
Jansen C, Bogs C, Verlinden W, et al. Shear-wave elastography of the liver and spleen identifies clinically significant portal hypertension: a prospective multicentre study. Liver Int. 2017;37(3):396-405. https://doi.org/10.1111/liv.13243
Thiele M, Hugger MB, Kim Y, et al. 2D shear wave liver elastography by aixplorer to detect portal hypertension in cirrhosis: an individual patient data meta-analysis. Liver Int. 2020;40(6):1435-1446.